| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 20 |
| 1 | FLUOROURACIL | 16 |
| 2 | FLUOROURACIL CREAM, 0.5% | 16 |
| 3 | CISPLATIN | 12 |
| 4 | NIVOLUMAB | 11 |
| 5 | MAGNESIUM OXIDE | 8 |
| 6 | AMLODIPINE BESYLATE | 7 |
| 7 | DICLOFENAC SODIUM | 7 |
| 8 | INSULIN GLARGINE | 7 |
| 9 | OXALIPLATIN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VADADUSTAT | 1 | 0.0033 |
| 1 | ROMOSOZUMAB-AQQG | 4 | 0.0003 |
| 2 | LEUCOVORIN CALCIUM | 5 | 0.0003 |
| 3 | VONOPRAZAN FUMARATE | 2 | 0.0002 |
| 4 | VASOPRESSIN | 1 | 0.0002 |
| 5 | CALCIUM FOLINATE | 1 | 0.0002 |
| 6 | FLUOROURACIL CREAM, 0.5% | 16 | 0.0002 |
| 7 | FLUOROURACIL | 16 | 0.0002 |
| 8 | POLATUZUMAB VEDOTIN | 2 | 0.0002 |
| 9 | OXYMETAZOLINE HYDROCHLORIDE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 31 | 0.0003 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 3 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 4 | Platinum-based Drug [EPC] | 22 | 0.0001 |
| 5 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 18 | 0.0001 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 3 | 0.0000 |